Literature DB >> 34855605

CT-Guided Survival Prediction of Esophageal Cancer.

Zhenyu Lin, Wenjie Cai, Wentai Hou, Yayuan Chen, Bingzong Gao, Runzhi Mao, Liansheng Wang, Zirong Li.   

Abstract

Survival prediction of esophageal cancer is an essential task for doctors to make personalized cancer treatment plans. However, handcrafted features from medical images need prior medical knowledge, which is usually limited and not complete, yielding unsatisfying survival predictions. To address these challenges, we propose a novel and efficient deep learning-based survival prediction framework for evaluating clinical outcomes before concurrent chemoradiotherapy. The proposed model consists of two key components: a 3D Coordinate Attention Convolutional Autoencoder (CACA) and an uncertainty-based jointly Optimizing Cox Model (UOCM). The CACA is built upon an autoencoder structure with 3D coordinate attention layers, capturing latent representations and encoding 3D spatial characteristics with precise positional information. Additionally, we designed an Uncertainty-based jointly Optimizing Cox Model, which jointly optimizes the CACA and survival prediction task. The survival prediction task models the interactions between a patient's feature signatures and clinical outcome to predict a reliable hazard ratio of patients. To verify the effectiveness of our model, we conducted extensive experiments on a dataset including computed tomography of 285 patients with esophageal cancer. Experimental results demonstrated that the proposed method achieved a C-index of 0.72, outperforming the state-of-the-art method.

Entities:  

Mesh:

Year:  2022        PMID: 34855605     DOI: 10.1109/JBHI.2021.3132173

Source DB:  PubMed          Journal:  IEEE J Biomed Health Inform        ISSN: 2168-2194            Impact factor:   7.021


  1 in total

1.  Development and validation of a deep learning model to predict survival of patients with esophageal cancer.

Authors:  Chen Huang; Yongmei Dai; Qianshun Chen; Hongchao Chen; Yuanfeng Lin; Jingyu Wu; Xunyu Xu; Xiao Chen
Journal:  Front Oncol       Date:  2022-08-10       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.